{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigpk5d52kp7uwlwky6z3jyl7mk5bkl5mhr3ibbi5xvssorfs5kuma",
    "uri": "at://did:plc:vv5cq7qjnr2fd5ytohsyyegf/app.bsky.feed.post/3ml5krztlsne2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib3ehjepp64itwcy5pwinipshkwrkj6g4jw2x7gribytmrgd5si7i"
    },
    "mimeType": "image/jpeg",
    "size": 206149
  },
  "path": "/2026/05/what-doctors-want-you-to-know-about-glp-1s-and-bone-loss/",
  "publishedAt": "2026-05-05T00:00:20.000Z",
  "site": "https://www.optimistdaily.com",
  "tags": [
    "Evergreen",
    "Health",
    "Lifestyle",
    "Medicine",
    "Nutrition & Wellness",
    "Science",
    "bone health weight loss",
    "GLP-1",
    "GLP-1 bone health",
    "GLP-1 side effects",
    "health",
    "osteoporosis GLP-1",
    "Ozempic bone loss",
    "Weight Loss",
    "weight loss bone density",
    "Wellness",
    "What doctors want you to know about GLP-1s and bone loss",
    "The Optimist Daily: Making Solutions the News"
  ],
  "textContent": "BY THE OPTIMIST DAILY EDITORIAL TEAM A study presented at the 2026 American Academy of Orthopaedic Surgeons annual meeting found that among nearly 147,000 adults with type 2 diabetes and obesity, GLP-1 use was associated with higher rates of osteoporosis, osteomalacia, and gout. The finding attracted a lot of attention, but the fine print matters […]\n\nThe post What doctors want you to know about GLP-1s and bone loss first appeared on The Optimist Daily: Making Solutions the News.",
  "title": "What doctors want you to know about GLP-1s and bone loss"
}